Clinical and bacteriological features of relapsing shunt-associated meningitis due to Acinetobacter baumannii

Eur J Clin Microbiol Infect Dis. 1995 Feb;14(2):130-4. doi: 10.1007/BF02111872.

Abstract

A case is reported of a patient who developed Acinetobacter baumannii meningitis ten days after a ventriculoperitoneal shunt had been placed for control of elevated intracranial pressure. Intravenous antimicrobial therapy was instituted with imipenem and tobramycin after shunt removal and insertion of a ventriculostomy tube. Following the placement of a ventriculoatrial shunt, clinical and microbiological relapse occurred that was eventually cured after complete removal of the ventricular drainage system and a second course of systemic antibiotics. Relapse was confirmed by modern molecular typing techniques including plasmid DNA fingerprinting and analysis of total genomic DNA by pulsed-field gel electrophoresis.

Publication types

  • Case Reports

MeSH terms

  • Acinetobacter / drug effects
  • Acinetobacter / genetics
  • Acinetobacter / isolation & purification*
  • Acinetobacter Infections / drug therapy
  • Acinetobacter Infections / microbiology*
  • Acinetobacter Infections / surgery
  • Adult
  • DNA, Bacterial / analysis
  • Drug Therapy, Combination / therapeutic use
  • Female
  • Humans
  • Imipenem / therapeutic use
  • Meningitis, Bacterial / drug therapy
  • Meningitis, Bacterial / microbiology*
  • Meningitis, Bacterial / surgery
  • Tobramycin / therapeutic use
  • Ventriculoperitoneal Shunt / adverse effects*

Substances

  • DNA, Bacterial
  • Imipenem
  • Tobramycin